Literature DB >> 16777522

Brugada electrocardiographic pattern due to tricyclic antidepressant overdose.

Mateen Akhtar1, Nora F Goldschlager.   

Abstract

The Brugada syndrome is an arrhythmogenic disease with characteristic coved ST-segment elevation 2 mm or greater in the right precordial leads (type 1 Brugada electrocardiogram [ECG] pattern or "Brugada sign"] and is estimated to be responsible for at least 20% of sudden deaths in patients with structurally normal hearts [Circulation 2005;111(5):659-70]. The Brugada sign has been described in asymptomatic patients after exposure to various drugs. As published reports of the drug-induced Brugada sign have become increasingly prevalent, there is growing interest in the mechanisms responsible for this acquired ECG pattern and its clinical significance. We report a case of a patient who developed the type 1 Brugada ECG pattern after intentional overdose of a tricyclic antidepressant agent, review the literature concerning tricyclic antidepressant agent-induced Brugada sign, discuss potential mechanisms, and evaluate the clinical significance of this ECG abnormality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16777522     DOI: 10.1016/j.jelectrocard.2006.02.005

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  10 in total

Review 1.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

2.  Simultaneous ST-segment elevation in inferior and precordial leads following ingestion of a lethal dose of desipramine: a novel Brugada-like EKG pattern.

Authors:  Mujeeb Sheikh; Khalil Kanjwal; Rahil Kasmani; Surendra Chutani; James D Maloney
Journal:  J Interv Card Electrophysiol       Date:  2009-07-29       Impact factor: 1.900

Review 3.  Subtype-selective targeting of voltage-gated sodium channels.

Authors:  Steve England; Marcel J de Groot
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

Review 4.  Brugada phenocopy: new terminology and proposed classification.

Authors:  Adrian Baranchuk; Timothy Nguyen; Min Hyung Ryu; Francisco Femenía; Wojciech Zareba; Arthur A M Wilde; Wataru Shimizu; Pedro Brugada; Andrés R Pérez-Riera
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

5.  Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.

Authors:  Yoshino Minoura; José M Di Diego; Hector Barajas-Martínez; Andrew C Zygmunt; Dan Hu; Serge Sicouri; Charles Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2011-10-28

Review 6.  Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest.

Authors:  Serge Sicouri; Charles Antzelevitch
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

Review 7.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

Review 8.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).

Authors:  Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2009-07-08       Impact factor: 6.343

Review 9.  Sudden cardiac death secondary to antidepressant and antipsychotic drugs.

Authors:  Serge Sicouri; Charles Antzelevitch
Journal:  Expert Opin Drug Saf       Date:  2008-03       Impact factor: 4.250

Review 10.  Brugada syndrome: should we be screening patients before prescribing psychotropic medication?

Authors:  Azizah Attard; Claire Stanniland; Stephen Attard; Andrew Iles; Kim Rajappan
Journal:  Ther Adv Psychopharmacol       Date:  2022-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.